Markets Move Sideways as Pharma Stocks Cool Off After Rally

The Nifty 50 opened about 38 points higher. It moved within a narrow band for most of the session. Intraday swings stayed close to 100 points, showing a lack of strong direction. By the close, the index added 11.30 points, or 0.05%, to settle at 24,364.35.

The BSE Sensex followed a similar path. It rose by 26.76 points, or 0.03%, to end at 78,520.30. This marks the fourth straight day of gains for both benchmarks. Still, the pace of the rise has slowed.

Global Cues Kept Traders Alert

Global developments played a role in shaping sentiment. Crude oil prices moved higher during the session. Concerns around shipping routes near the Strait of Hormuz stayed in focus.

Due to this, major markets across the globe are trading in red today. The same trend weighed on India. But somehow, Indian closed marginally in green.

Sector Performance

On the sectoral front, performance was not uniform. Out of the 11 sectors, 6 closed in green today. The rest ended in the red. Banks and financial stocks offered some support to the indices. Meanwhile, a few defensive sectors saw mild selling pressure.

Nifty Pharma Sees Mild Profit Booking

The Nifty Pharma index slipped by 0.18% on Monday. This came after a strong run in recent sessions.

The fall was not sharp, but it reflected profit booking. After a steady rise, some investors chose to lock in gains. This is a common pattern in the market.

Out of the pharma stocks, six advanced while fourteen declined. The broader trend in the sector remained weak for the day.

Outlook

In the coming sessions, a few factors are likely to guide the market. The movement in crude oil prices will remain important, as it can affect overall costs and sentiment. Updates on global geopolitical tensions will also be tracked closely, since any change can influence risk appetite.

At the same time, quarterly earnings from major companies will play a key role in shaping investor expectations. Domestic economic indicators will add further clarity, especially in assessing the strength of the economy.

Investors may also keep an eye on sector rotation. If pharma stabilises, it could regain strength. On the other hand, continued selling may shift focus to other sectors.

References:

https://www.nseindia.com/market-data/live-equity-market?symbol=NIFTY%20PHARMA

https://www.nseindia.com/market-data/live-market-indices